Incubate Comment In Response To The FTC’s Request For Comments On The Business Practices Of PBMs
Read Incubate's response to the FTC's Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their...
top of page
Incubate Coalition
Apr 13, 2022
Incubate Executive Director John Stanford Statement In Response To The Centers For Medicare & Medicaid Services’ Devastating Final National Coverage Determination For Certain Alzheimer’s Treatments
See Executive Director John Stanford's statement on CMS' Final NCD on Alzheimer's disease and how this will affect the future of...
Incubate Coalition
Feb 2, 2022
Moonshot Statement
Read Incubate Executive Director John Stanford's statement on President BIden's Moonshot initiative. Incubate Executive Director John...
Incubate Coalition
Nov 3, 2021
Leading Venture Capital Group Concerned With Prescription Drug Deal
"As investors in biotechnology and pharmaceuticals, we're highly concerned about the potential consequences of the new drug-pricing...
Incubate Coalition
Feb 25, 2021
FINAL NIST Oral Testimony – John Stanford, Incubate
We're here today to lend our strong support to the proposed clarification of the appropriate use of "march-in" authority under Bayh Dole....
Incubate Coalition
Jan 26, 2021
Most Favored Nation (MFN) Model Interim Final Rule With Comment Period
Incubate writes to share our strong concerns with the interim final rule (IFR) implementing the Most Favored Nation (MFN) Model. We...
bottom of page